Preclinical Evaluation of 68Ga-Labeled 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid-Ubiquicidin as a Radioligand for PET Infection Imaging

被引:66
作者
Ebenhan, Thomas [1 ,2 ,3 ,4 ]
Zeevaart, Jan Rijn [5 ]
Venter, Jacobus D. [6 ]
Govender, Thavendran [7 ]
Kruger, Gert H. [3 ]
Jarvis, Neil V. [4 ]
Sathekge, Mike M. [1 ,2 ]
机构
[1] Univ Pretoria, Dept Nucl Med, ZA-0001 Pretoria, South Africa
[2] Steve Biko Acad Hosp, ZA-0001 Pretoria, South Africa
[3] Univ KwaZulu Natal, Sch Chem, Durban, South Africa
[4] South African Nucl Energy Corp, Res & Dev, Pretoria, South Africa
[5] North West Univ, Dept Sci & Technol, Potchefstroom, South Africa
[6] Med Res Council South Africa, Pretoria, South Africa
[7] Univ KwaZulu Natal, Durban, South Africa
关键词
Ga-68; labeling; ubiquicidin; infection; UBI29-41; PET/CT Imaging; ANTIMICROBIAL PEPTIDES; AGENT; UBI;
D O I
10.2967/jnumed.113.128397
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Antimicrobial peptides such as ubiquicidin (UBI) are believed to differentiate between mammalian and bacterial or fungal cells. Tc-99m-UBI29-41 was previously tested for detecting infection in humans using SPECT. For the present study, the UBI fragment UBI29-41 (TGRAKRRMQYNRR) was conjugated to 1,4,7-triazacyclononane-triacetic acid (NOTA), radiolabeled with Ga-68, and investigated in a rabbit infection model. Methods: Ga-68 was obtained from a 1.85-GBq Ge-68/Ga-68 generator. New Zealand White rabbits were anesthetized with ketamine/medetomidine before tracer administration and placed in a clinical PET/CT scanner. Ga-68-1,4,7-triazacyclononane-1,4,7-triacetic-acid-ubiquicidin29-41 (Ga-68-NOTA-UBI29-41) was formulated in saline solution, and 101 41 MBq were administered intravenously. The tracer distribution was studied by PET/CT imaging in animals (a) that were healthy, (b) bearing muscular Staphylococcus aureus infections and turpentine oil-induced muscular inflammations, and (c) bearing ovalbumin-induced lung inflammations. Static PET/CT imaging was performed at different time intervals up to 120 min after injection. For calculation of target-to-nontarget ratios, standardized uptake values were normalized against healthy thigh muscle, representing nontargeted tissue. Results: PET/CT images of healthy animals showed predominant distribution in the kidneys, liver, and bladder; heart and spleen showed moderate, declining uptake, only. The biologic half-life in blood was 29 min. Urinary accumulation of Ga-68-NOTA-UBI29-41 peaked at 3.8 +/- 0.91 percentage injected dose per gram (%ID) at 120 min, and 88 +/- 5.2 %ID was recovered in total urine. Ga-68-NOTA-UBI29-41 imaging in (b) selectively visualized the muscular infection site and was differentiated from sterile inflammatory processes. Standardized uptake value ratios for muscles (infected/ inflamed) were 2.9 +/- 0.93, 2.9 +/- 0.50, 3.5 +/- 0.86, and 3.8 +/- 0.90 at 5, 30, 60, and 90 min after injection, respectively. Rabbit lungs with asthma showed insignificant uptake. Conclusion: Ga-68-NOTA-UBI29-41 was strongly localized in bacteria-infected areas and minimally detected in a sterile inflammation area in rabbitmuscles. The findings propose this compound to be an excellent first-line PET/CT tracer to allow the distinguishing of infection from inflammation.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 35 条
[1]  
Akhtar MS, 2005, J NUCL MED, V46, P567
[2]   An imaging analysis of 99mTc-UBI (29-41) uptake in S-aureus infected thighs of rabbits on ciprofloxacin treatment [J].
Akhtar, Muhammad Saeed ;
Khan, Muhammad Ejaz ;
Khan, Bashar ;
Irfanullah, Javaid ;
Afzal, Muhammad Shahzad ;
Khan, Muhammad Aleem ;
Nadeem, Muhammad Afzal ;
Jehangir, Mustansar ;
Imran, Muhammad Babar .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (06) :1056-1064
[3]   What will be required to bring 68Ga-labelled peptides into routine clinical use? [J].
Ballinger, James R. ;
Solanki, Kishor K. .
NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (12) :1109-1112
[4]   Methacholine and Ovalbumin Challenges Assessed by Forced Oscillations and Synchrotron Lung Imaging [J].
Bayat, Sam ;
Strengell, Satu ;
Porra, Liisa ;
Janosi, Tibor Z. ;
Petak, Ferenc ;
Suhonen, Heikki ;
Suortti, Pekka ;
Hantos, Zoltan ;
Sovijarvi, Anssi R. A. ;
Habre, Walid .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (04) :296-303
[5]   Imaging pulmonary inflammation with positron emission tomography: A biomarker for drug development [J].
Chen, Delphine L. ;
Schuster, Daniel P. .
MOLECULAR PHARMACEUTICS, 2006, 3 (05) :488-495
[6]   Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides [J].
de Blois, Erik ;
Chan, Ho Sze ;
Naidoo, Clive ;
Prince, Deidre ;
Krenning, Eric P. ;
Breeman, Wouter A. P. .
APPLIED RADIATION AND ISOTOPES, 2011, 69 (02) :308-315
[7]   The synthesis and chelation chemistry of DOTA-peptide conjugates [J].
De Leon-Rodriguez, Luis M. ;
Kovacs, Zoltan .
BIOCONJUGATE CHEMISTRY, 2008, 19 (02) :391-402
[8]   In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria [J].
Ferro-Flores, G ;
de Murphy, CA ;
Pedraza-López, M ;
Meléndez-Alafort, L ;
Zhang, YM ;
Rusckowski, M ;
Hnatowich, DJ .
NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (06) :597-603
[9]   Total Solid-Phase Synthesis of NOTA-Functionalized Peptides for PET Imaging [J].
Guerin, Brigitte ;
Ait-Mohand, Samia ;
Tremblay, Marie-Claude ;
Dumulon-Perreault, Veronique ;
Fournier, Patrick ;
Benard, Francois .
ORGANIC LETTERS, 2010, 12 (02) :280-283
[10]  
Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855